4 minute read
Apr. 2, 2023
QR-6401: An Attempt at AI for Macrocycles
QR-6401
oral, macrocyclic CDK2 inhibitor robust activity in ovarian cancer xenograft models AI generative modeling + opt. ACS. Med. Chem. Lett., February 8, 2023 Regor Therapeutics Group, Shanghai, CN